As we reported before, ELF3 expression is significantly increased in lung cancer patients compared to the normal control group, as well as in other types of cancer (e.g., breast cancer, cervical squamous cell carcinoma, and endocervical adenocarcinoma, stomach adenocarcinoma) (Fig. 1A). This evidence concerns the gene ELF3 and breast cancer.